Primary cutaneous mammary analog secretory carcinoma with ETV6-NTRK3 translocation

Sapna M. Amin, Adam Beattie, Xia Ling, Lawrence J Jennings, Joan Guitart*

*Corresponding author for this work

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Mammary analog secretory carcinoma (MASC) is a recently described tumor of the salivary glands named for its morphological and molecular similarity to secretory carcinoma of the breast. Many primary carcinomas arising from the adnexal glands also share similar morphology to those arising from the breast. Brandt et al first described primary cutaneous MASC in 2009 and since then only 2 other cases have been reported. Herein, we describe a long-standing mass on the arm of an otherwise healthy 40-year-old female. Histologic examination revealed a circumscribed but unencapsulated, nodular tumor composed of bland epithelial cells arranged in solid and microcystic growth patterns. The cells showed vacuolated cytoplasm and round to oval nuclei with vesicular chromatin. Intraluminal homogenous eosinophilic secretions were present. Mitotic figures were not identified. The tumor cells stained positive for CK8/18, CK7, and S100 but were negative for other markers performed, including estrogen receptor, progesterone receptor, HER2/neu, paired box 8 (PAX8), and thyroid transcription factor 1 (TTF1). As the patient clinically had no other masses or known carcinomas, a diagnosis of primary cutaneous MASC was rendered. The ETV6-NTRK3 fusion transcript was subsequently detected by reverse transcriptase polymerase chain reaction amplification, further supporting the diagnosis. We present this case to review the histologic features of MASC and highlight the importance of recognizing this lesion not only as a possible cutaneous metastasis but also as a primary cutaneous tumor.

Original languageEnglish (US)
Pages (from-to)842-845
Number of pages4
JournalAmerican Journal of Dermatopathology
Volume38
Issue number11
DOIs
StatePublished - Nov 1 2016

Fingerprint

Skin
Neoplasms
Carcinoma
Progesterone Receptors
Salivary Glands
Reverse Transcriptase Polymerase Chain Reaction
Estrogen Receptors
Chromatin
Cytoplasm
Breast
Arm
Epithelial Cells
Neoplasm Metastasis
Mammary Analogue Secretory Carcinoma
Growth
thyroid nuclear factor 1
Secretory breast carcinoma
PAX1 transcription factor

Keywords

  • ETV6-NTRK3 fusion
  • adnexal
  • cutaneous mammary analog secretory carcinoma
  • mammary analog secretory carcinoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Dermatology

Cite this

@article{e15f2a2ae34643ae83f7c709d30485d1,
title = "Primary cutaneous mammary analog secretory carcinoma with ETV6-NTRK3 translocation",
abstract = "Mammary analog secretory carcinoma (MASC) is a recently described tumor of the salivary glands named for its morphological and molecular similarity to secretory carcinoma of the breast. Many primary carcinomas arising from the adnexal glands also share similar morphology to those arising from the breast. Brandt et al first described primary cutaneous MASC in 2009 and since then only 2 other cases have been reported. Herein, we describe a long-standing mass on the arm of an otherwise healthy 40-year-old female. Histologic examination revealed a circumscribed but unencapsulated, nodular tumor composed of bland epithelial cells arranged in solid and microcystic growth patterns. The cells showed vacuolated cytoplasm and round to oval nuclei with vesicular chromatin. Intraluminal homogenous eosinophilic secretions were present. Mitotic figures were not identified. The tumor cells stained positive for CK8/18, CK7, and S100 but were negative for other markers performed, including estrogen receptor, progesterone receptor, HER2/neu, paired box 8 (PAX8), and thyroid transcription factor 1 (TTF1). As the patient clinically had no other masses or known carcinomas, a diagnosis of primary cutaneous MASC was rendered. The ETV6-NTRK3 fusion transcript was subsequently detected by reverse transcriptase polymerase chain reaction amplification, further supporting the diagnosis. We present this case to review the histologic features of MASC and highlight the importance of recognizing this lesion not only as a possible cutaneous metastasis but also as a primary cutaneous tumor.",
keywords = "ETV6-NTRK3 fusion, adnexal, cutaneous mammary analog secretory carcinoma, mammary analog secretory carcinoma",
author = "Amin, {Sapna M.} and Adam Beattie and Xia Ling and Jennings, {Lawrence J} and Joan Guitart",
year = "2016",
month = "11",
day = "1",
doi = "10.1097/DAD.0000000000000590",
language = "English (US)",
volume = "38",
pages = "842--845",
journal = "American Journal of Dermatopathology",
issn = "0193-1091",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

Primary cutaneous mammary analog secretory carcinoma with ETV6-NTRK3 translocation. / Amin, Sapna M.; Beattie, Adam; Ling, Xia; Jennings, Lawrence J; Guitart, Joan.

In: American Journal of Dermatopathology, Vol. 38, No. 11, 01.11.2016, p. 842-845.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Primary cutaneous mammary analog secretory carcinoma with ETV6-NTRK3 translocation

AU - Amin, Sapna M.

AU - Beattie, Adam

AU - Ling, Xia

AU - Jennings, Lawrence J

AU - Guitart, Joan

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Mammary analog secretory carcinoma (MASC) is a recently described tumor of the salivary glands named for its morphological and molecular similarity to secretory carcinoma of the breast. Many primary carcinomas arising from the adnexal glands also share similar morphology to those arising from the breast. Brandt et al first described primary cutaneous MASC in 2009 and since then only 2 other cases have been reported. Herein, we describe a long-standing mass on the arm of an otherwise healthy 40-year-old female. Histologic examination revealed a circumscribed but unencapsulated, nodular tumor composed of bland epithelial cells arranged in solid and microcystic growth patterns. The cells showed vacuolated cytoplasm and round to oval nuclei with vesicular chromatin. Intraluminal homogenous eosinophilic secretions were present. Mitotic figures were not identified. The tumor cells stained positive for CK8/18, CK7, and S100 but were negative for other markers performed, including estrogen receptor, progesterone receptor, HER2/neu, paired box 8 (PAX8), and thyroid transcription factor 1 (TTF1). As the patient clinically had no other masses or known carcinomas, a diagnosis of primary cutaneous MASC was rendered. The ETV6-NTRK3 fusion transcript was subsequently detected by reverse transcriptase polymerase chain reaction amplification, further supporting the diagnosis. We present this case to review the histologic features of MASC and highlight the importance of recognizing this lesion not only as a possible cutaneous metastasis but also as a primary cutaneous tumor.

AB - Mammary analog secretory carcinoma (MASC) is a recently described tumor of the salivary glands named for its morphological and molecular similarity to secretory carcinoma of the breast. Many primary carcinomas arising from the adnexal glands also share similar morphology to those arising from the breast. Brandt et al first described primary cutaneous MASC in 2009 and since then only 2 other cases have been reported. Herein, we describe a long-standing mass on the arm of an otherwise healthy 40-year-old female. Histologic examination revealed a circumscribed but unencapsulated, nodular tumor composed of bland epithelial cells arranged in solid and microcystic growth patterns. The cells showed vacuolated cytoplasm and round to oval nuclei with vesicular chromatin. Intraluminal homogenous eosinophilic secretions were present. Mitotic figures were not identified. The tumor cells stained positive for CK8/18, CK7, and S100 but were negative for other markers performed, including estrogen receptor, progesterone receptor, HER2/neu, paired box 8 (PAX8), and thyroid transcription factor 1 (TTF1). As the patient clinically had no other masses or known carcinomas, a diagnosis of primary cutaneous MASC was rendered. The ETV6-NTRK3 fusion transcript was subsequently detected by reverse transcriptase polymerase chain reaction amplification, further supporting the diagnosis. We present this case to review the histologic features of MASC and highlight the importance of recognizing this lesion not only as a possible cutaneous metastasis but also as a primary cutaneous tumor.

KW - ETV6-NTRK3 fusion

KW - adnexal

KW - cutaneous mammary analog secretory carcinoma

KW - mammary analog secretory carcinoma

UR - http://www.scopus.com/inward/record.url?scp=84992130239&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992130239&partnerID=8YFLogxK

U2 - 10.1097/DAD.0000000000000590

DO - 10.1097/DAD.0000000000000590

M3 - Article

C2 - 27763904

AN - SCOPUS:84992130239

VL - 38

SP - 842

EP - 845

JO - American Journal of Dermatopathology

JF - American Journal of Dermatopathology

SN - 0193-1091

IS - 11

ER -